Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks): An alternative in the treatment of locally advanced head and neck cancer

Strahlentherapie und Onkologie

Volumn 187, Issue 10, 2011, Pages 651-655

  Kubes, Jiri ^a   Cvek, Jakub ^b   Vondracek, Vladimir ^a   Pala, Miloslav ^a   Feltl, David ^b  

^a UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

Author keywords

Accelerated radiotherapy; Concomitant boost; Head and neck cancer

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNX DISORDER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PHARYNX DISEASE; RADIATION DOSE; SALIVARY GLAND; SKIN DISEASE; TREATMENT PLANNING;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 80755171186     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2246-2     Document Type: Article

References (22)

1. J.A. Bonner P.M. Harari J. Giralt 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 567 78 16467544 10.1056/NEJMoa053422 1:CAS:528:DC%2BD28Xhtleksbs%3D (Pubitemid 43209104)
2. J. Bourhis A. Etessami P. Wilbault 2004 Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations Curr Opin Oncol 16 215 9 15069315 10.1097/00001622-200405000-00004 (Pubitemid 38543695)
3. Denham JW, Kron T. Extinction of the weakest. Int J Radiat Oncol Biol 2001;51:807-19.
4. S. Dische M. Saunders A. Barrett 1997 A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother Oncol 44 123 36 9288840 10.1016/S0167-8140(97)00094-7 1:STN:280:DyaK2svjtlWksw%3D%3D (Pubitemid 27345199)
5. J.G. Eriksena T. Steinicheb J. Overgaard 2005 The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study Radiother Oncol 74 93 100 10.1016/j.radonc.2004.12.018 (Pubitemid 40331865)
6. A. Farrag M. Voordeckers K. Tournel 2010 Pattern of failure after helical tomotherapy in head and neck cancer Strahlenther Onkol 186 511 6 20803182 10.1007/s00066-010-2130-5
7. J.W. Fowler 2008 Optimum overall times II: extended modelling for head and neck radiotherapy Clin Oncol 20 113 26 10.1016/j.clon.2007.11.003 1:STN:280:DC%2BD1c7gt1Omtg%3D%3D
8. J.W. Fowler 2007 Is there an optimal overall time for head and neck radiotherapy? A review, with new modelling Clin Oncol 19 8 22 10.1016/j.clon.2006.09.008 1:STN:280:DC%2BD2s7gsFKhtQ%3D%3D (Pubitemid 46044065)
9. J.F. Fowler P.M. Harari F. Leborgne 2009 Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in Alfred fractionation Schedule Radiotherap Oncol 69 161 8 10.1016/S0167-8140(03)00231-7
10. K.K. Fu T.F. Pajak A. Trotti 2000 A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 7 16 10924966 10.1016/S0360-3016(00)00663-5 1:STN:280: DC%2BD3czps1aqsQ%3D%3D (Pubitemid 30488207)
11. J.S. Ghoshal I. Goda T.S. Mallick 2008 Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck: a phase III trial from a single institution in India Clin Oncol 20 212 20 10.1016/j.clon.2008.01.011 1:STN:280:DC%2BD1c7osVygsQ%3D%3D (Pubitemid 351372912)
12. C. Giro B. Berger E. Bölke 2009 High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes Radiother Oncol 90 166 71 18977050 10.1016/j.radonc.2008.09.007 1:CAS:528:DC%2BD1MXhvFGkt7o%3D
13. G.B. Gun J.E. Endres B. Parker 2010 A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma Strahlenther Onkol 1 489 95 10.1007/s00066-010-2093-6
14. J.H. Hendry S.A. Roberts N.J. Slevin 1994 Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada Radiother Oncol 31 14 22 8041895 10.1016/0167-8140(94)90409-X 1:STN:280:DyaK2czhs1yitw%3D%3D (Pubitemid 24167586)
15. J.C. Horiot R. LeFur T. N'Guyen 1992 Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 231 41 1480768 10.1016/0167-8140(92)90242-M 1:STN:280:DyaK3s7is1GqsA%3D%3D (Pubitemid 23000765)
16. J. Overgaard H.S. Hansen L. Specht 2003 Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 20 933 40 10.1016/S0140-6736(03)14361-9 (Pubitemid 37159288)
17. J.P. Pignon J. Bourhis C. Domenge MACH-NC Collaborative Group 2000 Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data Lancet 355 949 55 10768432 1:STN:280:DC%2BD3c3ivV2iuw%3D%3D (Pubitemid 30148259)
18. S.A. Roberts J.H. Hendry A.E. Brewster 1994 The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor Br J Radiol 67 790 4 8087485 10.1259/0007-1285-67-800-790 1:STN:280:DyaK2czntleqtw%3D%3D (Pubitemid 24280130)
19. K. Skladowski B. Macejewski B. Pileski 1996 Randomized clinical trial of accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on therapy toxicity Radiother Oncol 40 137 45 8884967 10.1016/S0167-8140(96)80155-1 (Pubitemid 26276678)
20. D. Steinmann B. Cerny J.H. Karstens 2009 Chemoradiotherapy with weekly cisplatin 40 mg/m2 in 103 head-and-neck cancer patients Strahlenther Onkol 185 682 8 19806334 10.1007/s00066-009-1989-5
21. C.H. Terhaard H.B. Kal G.J. Hordijk 2005 Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3 Int J Radiat Oncol Biol Phys 62 62 9 15850903 10.1016/j.ijrobp.2004.09.007 (Pubitemid 40591924)
22. S. Tribius S. Kronemann Y. Kilic 2009 Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck Strahlenther Onkol 185 675 81 19806333 10.1007/s00066-009-1992-x